Kingsley Ekwueme, a professor and pioneering urological and robotic surgeon, is transforming prostate cancer treatment in ...

According to investigators, there is no validated PSA-based endpoint to compare oncologic outcomes after radical prostatectomy and radiation therapy for localized prostate cancer.

Professor Kingsley Ekwueme is a distinguished urologist and robotic surgeon whose expertise in minimally invasive procedures ...

Auron will present data highlighting the activity of AUTX-703, its oral, potent and selective degrader targeting KAT2A/B in cell lines and patient derived organoid models (PDXO) of neuroendocrine ...

and castrate resistant prostate cancer (CRPC). KAT2A/B is a histone acetyltransferase that is associated with multiple tumor types. Details for Auron’s poster presentation are below and can be ...

More than 2 decades have passed since I became the first full-time editor of Renal & Urology News. During that time, the ...

The Puddletown Nomads, who play in the Dorchester Skittles League, have been collecting money for Prostate Cancer UK during match nights. The team, who play out of Goldies pub, said they are doing ...

a potent and selective allosteric inhibitor of PRC2 to treat prostate cancer, has been accepted for poster presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting ...

Radiographic disappearance of metastases could be a surrogate marker for outcomes among patients treated for metastatic ...

Edwards invoked Eroseanna "Rose" Robinson, a high jumper who, incensed by Jim Crow, refused to stand for the national anthem ...

Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new ...

MINDFuL Phase II Blinded, Randomized, Placebo-Controlled Data Anticipated June 2025 Boca Raton, Florida, April 01, 2025 (GLOBE NEWSWIRE) -- ...